<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04139694</url>
  </required_header>
  <id_info>
    <org_study_id>RP-19-002</org_study_id>
    <nct_id>NCT04139694</nct_id>
  </id_info>
  <brief_title>Improving Insulin Resistance in Gynecological Cancer Patients</brief_title>
  <official_title>Improving Insulin Resistance in Gynecological Cancer Patients Post Treatment Using Integrative and Functional Food Plan With or Without Cinnamon Supplementation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Woman's</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Woman's Hospital, Louisiana</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dietitians in Integrative and Functional Medicine DPG</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Woman's</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a research study to see if the addition of cinnamon to a provided food plan would
      improve insulin resistance in gynecological cancer patients. One study suggests that patients
      with gynecological cancers are more likely to be insulin resistant and/or have higher levels
      of fasting insulin. The study will be 24 weeks in length.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    unable to procure supplement for clinical trial use
  </why_stopped>
  <start_date type="Actual">March 16, 2020</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in mean glucose concentration</measure>
    <time_frame>24 weeks</time_frame>
    <description>To determine whether the addition of cinnamon to the implementation of an integrative and functional (IF) food plan will show a difference of 10 mg% in the mean glucose concentration measured when comparing the baseline and 24 week Oral Glucose Tolerance Test (OGTT) glucose levels.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>body mass index (BMI)</measure>
    <time_frame>24 weeks</time_frame>
    <description>To determine whether the addition of cinnamon to the implementation of an IF food plan will improve BMI more than just dietary intervention alone. BMI will be calculated by dividing the participant's weight by her height squared.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body composition</measure>
    <time_frame>24 weeks</time_frame>
    <description>To determine whether the addition of cinnamon to the implementation of an IF food plan will improve the ratio of fat mass to fat free mass more than just dietary intervention alone. We will measure using a Fit3D scanner that uses infrared cameras to estimate fat mass and fat free mass.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>glucose tolerance</measure>
    <time_frame>24 weeks</time_frame>
    <description>To determine whether the addition of cinnamon to the implementation of an IF food plan will improve glucose tolerance levels more than just dietary intervention alone. It will be measured using the results of the baseline and final 2-hour Oral Glucose Tolerance Test which measures glucose and insulin at 4 time points.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Insulin Resistance</condition>
  <arm_group>
    <arm_group_label>Cinnamon with Food Plan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group of ladies who will undergo testing, receive dietary intervention, and take cinnamon supplements.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Food Plan Only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group of ladies who will undergo testing, receive dietary intervention, but will not get cinnamon supplements.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Food plan with cinnamon supplementation</intervention_name>
    <description>cinnamon twice daily plus follow Cardiometabolic diet</description>
    <arm_group_label>Cinnamon with Food Plan</arm_group_label>
    <other_name>Gaia Herbs Cinnamon Bark</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Food plan without cinnamon supplementation</intervention_name>
    <description>Cardiometabolic diet only</description>
    <arm_group_label>Food Plan Only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  previously diagnosed with gynecological cancer and has completed all surgical
             intervention, chemotherapy, and/or radiation at least 3 months prior to enrollment but
             not greater than 24 months

          -  post-menopausal

          -  BMI &gt; 25 but &lt; 40

        Exclusion Criteria:

          -  no previous diagnosis of diabetes

          -  no other cancer diagnosis (excluding skin)

          -  no chronic use of medication(s) interfering with glucose metabolism
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Woman's Hospital</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70809</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>October 10, 2019</study_first_submitted>
  <study_first_submitted_qc>October 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2019</study_first_posted>
  <last_update_submitted>May 14, 2020</last_update_submitted>
  <last_update_submitted_qc>May 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Woman's</investigator_affiliation>
    <investigator_full_name>Brooke Schoonenberg</investigator_full_name>
    <investigator_title>Nutrition Services Manager</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 7, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/94/NCT04139694/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

